`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`
`NOVARTIS PHARMA AG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owner.
`
`
`
`
`
`Case No. IPR2021-00816
`U.S. Patent No. 9,220,631
`
`
`
`
`
`UPDATED POWER OF ATTORNEY FOR REGENERON
`PHARMACEUTICALS, INC.
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner Regeneron Pharmaceuticals,
`
`Inc. hereby appoints the following practitioners as their attorneys to transact all
`
`business in the United States Patent & Trademark Office connected to the above-
`
`captioned Inter Partes Review of U.S. Patent No. 9,220,631:
`
`LEAD COUNSEL
`Elizabeth Stotland Weiswasser
`Reg. No. 55,721
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`elizabeth.weiswasser@weil.com
`Phone: 212-310-8022
`Fax: 212-310-8007
`
`BACK-UP COUNSEL
`Anish Desai
`Reg. No. 73, 760
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY. 10153
`anish.desai@weil.com
`Phone: 212-310-8730
`Fax: 212-310-8007
`Christopher M. Pepe
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7153
`F: 202-857-0940
`christopher.pepe@weil.com
`USPTO Reg. No. 73,851
`Natalie C. Kennedy
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8227
`F: 212-310-8007
`natalie.kennedy@weil.com
`USPTO Reg. No. 68,511
`Andrew P. Gesior
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8244
`F: 212-310-8007
`andrew.gesior@weil.com
`USPTO Reg. No. 76,588
`
`1
`
`
`
`etra Scamborova
`dmitted
`Pro Hae Vice, (Updated)
`
`
`egeneron Pharmaceuticals, Inc.
`77 Old Saw Mill River Road
`
`arrytown, NY I 0591
`
`14-847-761 I
`etra.scamborova@regeneron.com
`ames T. Evans (Updated)
`
`
`egeneron Pharmaceuticals, Inc.
`77 Old Saw Mill River Road
`
`arrytown, NY 10591
`14-847-7000
`
`· ames.evans@regeneron.com
`
`SPTO Reg. No. 64,377
`
`
`
`
`
`
`
`
`
`
`
`The undersigned has the authority to execute this document on behalf of
`
`
`
`
`
`Regeneron Pharmaceuticals, Inc.
`
`Dated: January 13, 2022
`
`Vice President,
`
`
`Associate General Counsel
`
`
`Regeneron Pharmaceuticals, Inc.
`
`2
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that on January 18, 2022, the foregoing
`
`REGENERON PHARMACEUTICALS, INC.’S UPDATED POWER OF
`
`ATTORNEY was served via electronic mail, upon the following:
`
`Elizabeth J. Holland
`Linnea P. Cipriano
`Goodwin Procter LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018-1405
`eholland@goodwinlaw.com
`lcipriano@goodwinlaw.com
`
`William G. James
`Goodwin Procter LLP
`1900 N St. N.W.
`Washington, D.C. 20036-1612
`wjames@goodwinlaw.com
`
`Joshua Weinger
`Nicholas K. Mitrokostas
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210
`JWeinger@goodwinlaw.com
`nmitrokostas@goodwinlaw.com
`
`DG-NovartisNDNYPFS@goodwinlaw.com
`
` 1
`
`/Ryan Sotnick/
`Ryan Sotnick
`IP Paralegal
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`Phone (202) 682-7000
`ryan.sotnick@weil.com
`
`3
`
`